Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-15 Sale | 2023-09-18 6:54 pm | Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer | 6,201 | $1.5206 | $9,429 | 47,674 (Direct) | View |
| 2023-06-07 Purchase | 2023-06-09 4:26 pm | Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M Chief Financial Officer | 100,000 | $1.4549 | $145,490 | 100,000 (Direct) | View |
| 2023-03-15 Sale | 2023-03-17 6:02 pm | Adverum Biotechnologies Inc. | ADVM | Riley Brigit Chief Scientific Officer | 7,299 | $0.7816 | $5,705 | 117,435 (Direct) | View |
| 2023-03-15 Sale | 2023-03-17 6:02 pm | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Operating Officer | 13,360 | $0.7816 | $10,442 | 265,891 (Direct) | View |
| 2023-03-15 Sale | 2023-03-17 6:01 pm | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, President and Director | 41,239 | $0.7816 | $32,232 | 692,141 (Direct) | View |
| 2022-09-19 Sale | 2022-09-21 8:01 pm | Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer | 4,272 | $1.0697 | $4,570 | 39,061 (Direct) | View |
| 2022-09-19 Sale | 2022-09-21 8:00 pm | Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer | 6,058 | $1.0696 | $6,480 | 47,875 (Direct) | View |
| 2022-09-19 Sale | 2022-09-21 7:59 pm | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section | 13,305 | $1.0697 | $14,232 | 273,251 (Direct) | View |
| 2022-09-19 Sale | 2022-09-21 7:58 pm | Adverum Biotechnologies Inc. | ADVM | Riley Brigit Chief Scientific Officer | 7,266 | $1.0697 | $7,772 | 118,734 (Direct) | View |
| 2022-09-19 Sale | 2022-09-21 7:57 pm | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, President and Director | 41,082 | $1.0696 | $43,941 | 727,380 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-03 Option Award | 2023-09-05 4:14 pm | N/A 2033-08-02 | Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M Chief Financial Officer | 850,000 | $0 | 850,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 6:19 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:17 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:15 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Whitcup Scott M Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:13 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:10 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:05 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:03 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Hong Soo Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:02 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Machado Patrick Director | 52,500 | $0 | 92,500 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:24 pm | N/A 2033-02-28 | Adverum Biotechnologies Inc. | ADVM | Riley Brigit Chief Scientific Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:24 pm | N/A 2033-02-28 | Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:23 pm | N/A 2033-02-28 | Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:22 pm | N/A 2033-02-28 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Operating Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:21 pm | N/A 2033-02-28 | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, President and Director | 930,000 | $0 | 930,000 (Direct) | View |
Ownership | 2022-12-15 5:27 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M Chief Financial Officer | 0 | $0 | 0 (Direct) | View |
| 2022-09-14 Option Award(A) | 2022-09-21 7:55 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer | 33,333 | $0 | 43,333 (Direct) | View |
| 2022-09-14 Option Award | 2022-09-16 7:26 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer | 25,000 | $0 | 35,000 (Direct) | View |
| 2022-09-14 Option Award | 2022-09-16 7:25 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer | 33,333 | $0 | 53,933 (Direct) | View |
| 2022-09-14 Option Award | 2022-09-16 7:00 pm | N/A 2032-09-13 | Adverum Biotechnologies Inc. | ADVM | Riley Brigit Chief Scientific Officer | 164,413 | $0 | 164,413 (Direct) | View |
| 2022-09-14 Option Award | 2022-09-16 7:00 pm | N/A 2032-09-13 | Adverum Biotechnologies Inc. | ADVM | Rakow John SVP, Genl Counsel, Acting CFO | 118,070 | $0 | 118,070 (Direct) | View |
| 2022-09-14 Option Award | 2022-09-16 6:59 pm | N/A 2032-09-13 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section | 394,771 | $0 | 394,771 (Direct) | View |
| 2022-09-14 Option Award | 2022-09-16 6:58 pm | N/A 2032-09-13 | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, President and Director | 1,260,000 | $0 | 1,260,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:23 pm | N/A 2032-06-09 | Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:22 pm | N/A 2032-06-09 | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:22 pm | N/A 2032-06-09 | Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:21 pm | N/A 2032-06-09 | Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:20 pm | N/A 2032-06-09 | Adverum Biotechnologies Inc. | ADVM | Whitcup Scott M Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:19 pm | N/A 2032-06-09 | Adverum Biotechnologies Inc. | ADVM | Machado Patrick Director | 52,500 | $0 | 52,500 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 4:39 pm | N/A 2032-06-07 | Adverum Biotechnologies Inc. | ADVM | Rakow John SVP, Genl Counsel, Acting CFO | 250,000 | $0 | 250,000 (Direct) | View |
Ownership | 2022-06-10 4:37 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Rakow John SVP, Genl Counsel, Acting CFO | 0 | $0 | 423,771 (Direct) | View |